Related Experiment Video
Updated: May 8, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Skin Metastasis From Solid Tumors: Is Targeted Therapy Making an Impact?
Mohamed Arshad1, Ashwin J Paul2, Raghul Kumar3
1Medical Oncology, Madras Medical College, Chennai, IND.
Abstract:
Cutaneous metastasis from solid tumors is a rare manifestation that presents in the clinic. It is usually indicative of poor prognosis, with a poor response to conventional chemotherapy. The introduction of targeted therapy has changed the treatment paradigm in oncology, improving the quality of life and survival of all cancer patients. Here, we present two cases of solid tumors with skin metastases that had a good response to targeted systemic therapy. This case report also discusses the various modes of presentation and the therapeutic options for metastatic cutaneous lesions from solid tumors.
Insights
Cutaneous metastasis from solid tumors, though rare, often indicates a poor prognosis. Targeted therapy offers a promising treatment approach, improving outcomes for patients with skin metastases.
Area of Science:
- Oncology
- Dermatology
- Medical Oncology
Background:
- Cutaneous metastasis from solid tumors is uncommon and typically associated with a poor prognosis and limited response to traditional chemotherapy.
- Targeted therapy has revolutionized cancer treatment, enhancing patient survival and quality of life.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

